Technical Analysis for CRL - Charles River Laboratories International, Inc.

Grade Last Price % Change Price Change
A 396.32 0.78% 3.07
CRL closed up 0.78 percent on Friday, July 23, 2021, on 45 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Aug 3
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical CRL trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
New 52 Week Closing High Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
New 52 Week High Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Older End-of-Day Signals for CRL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Charles River Laboratories International, Inc. Description

Charles River Laboratories International, Inc., together with its subsidiaries, provides research models and associated services, and outsourced preclinical services to accelerate the drug discovery and development process. It operates in two segments, Research Models and Services (RMS), and Preclinical Services (PCS). The RMS segment is involved in the production and sale of research model strains, principally genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also offers a range of services to assist customers in the drug discovery and development process, which include genetically engineered models and services, insourcing solutions, discovery research services, research animal diagnostic services, endotoxin and microbial detection products and services, and avian vaccine products and services. The PCS segment provides preclinical services, including both in vivo and in vitro studies, supportive laboratory services, and strategic preclinical consulting and program management to support product development. This segment offers services in the areas of bioanalysis, pharmacokinetics, and drug metabolism; toxicology; and pathology services, as well as testing of biologics and devices frequently outsourced by pharmaceutical and biotechnology companies. The company serves pharmaceutical companies, biotechnology companies, government agencies, hospitals, and academic institutions worldwide. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: S&P 500 Biotechnology Life Sciences Pharmaceutical Industry Pharmaceutical IBD 50 Drug Discovery Research Services Lab Testing In Vitro Metabolism Laboratory Services Toxicology Diagnostic Services Pathology Pharmacokinetics Clinical Services Contract Research Organizations Detection Products Toxicology Testing Vaccine Products Drug Metabolism Pathology Services Pre Clinical Development

Is CRL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 397.605
52 Week Low 195.48
Average Volume 528,297
200-Day Moving Average 292.17
50-Day Moving Average 356.45
20-Day Moving Average 380.12
10-Day Moving Average 385.53
Average True Range 6.42
ADX 46.12
+DI 30.33
-DI 10.87
Chandelier Exit (Long, 3 ATRs) 378.33
Chandelier Exit (Short, 3 ATRs) 382.55
Upper Bollinger Bands 395.64
Lower Bollinger Band 364.59
Percent B (%b) 1.02
BandWidth 8.17
MACD Line 9.46
MACD Signal Line 9.45
MACD Histogram 0.0103
Fundamentals Value
Market Cap 19.71 Billion
Num Shares 49.7 Million
EPS 6.00
Price-to-Earnings (P/E) Ratio 66.09
Price-to-Sales 4.03
Price-to-Book 5.94
PEG Ratio 1.70
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 401.91
Resistance 3 (R3) 401.72 399.66 400.98
Resistance 2 (R2) 399.66 398.24 399.76 400.67
Resistance 1 (R1) 397.99 397.36 398.83 398.18 400.36
Pivot Point 395.94 395.94 396.35 396.03 395.94
Support 1 (S1) 394.27 394.51 395.10 394.46 392.28
Support 2 (S2) 392.21 393.63 392.31 391.97
Support 3 (S3) 390.54 392.21 391.66
Support 4 (S4) 390.73